The molecular mechainsms driving cellular senescence, where-by cells simultaneously withdraw permanently from the cell cycle and escape apoptosis, remain elusive.
A strikingly important feature of senescence cells (SC) is their low-level senescence-associated secretory phenotype (SASP), characterised by a wide variety of cytokines, chemokines, growth factors and proteases.
This SASP is identified to accumulate with age, creating a deleterious low-level chronic inflammatory microenvironment. This mechanism is hypothesised to accelerate/promote ageing and age-related diseases, including cancer.
Unsurprisingly, discovery and development of therapies that can target the destruction of SCs is a highly attractive and vibrant area of R&D.
Project Aims: (i) Identify novel/validated protein-protein interactions (PPIs) found to drive ageing/age-related disease. (ii) Discover and develop highly selective cell-penetrating peptide disrupters (CPP-D) of said PPIs. (iii) Develop biochemistry/pharmacology of CPP-Ds. (iv) Demonstrate disruption of PPI using developed CPP-Ds. (v) Establish appropriate senescence associated cellular models/assays. (vi) Validate senolytic capabilities of developed CPP-Ds in vitro (vii) Identify LEAD senolytic compound(s) for appropriate pre-clinical assessment.
TO APPLY, CLICK ’VISIT WEBSITE’
All fees, consumables, stipend for 3.5 years are covered.